In addition to PLK1, PGCCs up-regulated CDC20 and CCNB1, which are associated with aneuploidy/polyploidy, adverse clinical outcomes of breast cancer patients, and resistance to adjuvant therapy62–64. Here, CDC20 is linked to breast carcinoma.